AB Science granted European patent for masitinib in treating sickle cell disease until 2040

AB Science granted European patent for masitinib in treating sickle cell disease until 2040

Our lead product, masitinib, is a tyrosine kinase inhibitor that targets mast cells and macrophages, important cells for immunity, through more than 20 indications in oncology, inflammatory diseases, and central nervous system diseases. AB Science has its headquarters in Paris and is listed on Euronext Paris (ticker: AB). For more information, please visit our website: … Read more

Title: Increased Disease Risk for Polar Bears in a Warming Arctic

Title: Increased Disease Risk for Polar Bears in a Warming Arctic

USGS In a warming Arctic, polar bears are spending more time on land As the Arctic warms, polar bears face an increasing risk of contracting viruses, bacteria, and parasites that they were less likely to encounter just 30 years ago, research has shown. A study examining blood samples from bears in the Chukchi Sea – … Read more